Use of bisphosphonates in multiple myeloma: IMWG response to Mayo Clinic consensus statement - Reply

被引：1
|
作者：
Lacy, Martha Q. [1 ]
Rajkumar, S. Vincent [1 ]
机构：
[1] Mayo Clin, Coll Med, Myeloma Grp, Rochester, MN 55905 USA
来源：
MAYO CLINIC PROCEEDINGS | 2007年 / 82卷 / 04期
关键词：
D O I：
10.4065/82.4.517
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：517 / 518
页数：2
相关论文
共 50 条
  • [21] Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma
    Dimopoulos, M. A.
    Leleu, X.
    Palumbo, A.
    Moreau, P.
    Delforge, M.
    Cavo, M.
    Ludwig, H.
    Morgan, G. J.
    Davies, F. E.
    Sonneveld, P.
    Schey, S. A.
    Zweegman, S.
    Hansson, M.
    Weisel, K.
    Mateos, M. V.
    Facon, T.
    Miguel, J. F. S.
    LEUKEMIA, 2014, 28 (08) : 1573 - 1585
  • [22] Use of bisphosphonates in patients with myeloma and renal failure - Reply
    Rajkumar, SV
    Gertz, MA
    Kyle, RA
    Greipp, PR
    MAYO CLINIC PROCEEDINGS, 2003, 78 (01) : 118 - 118
  • [23] Imaging in Multiple Myeloma - Independent review perspective for IMWG 2016 response assessment
    Narang, Jayant
    Bajpai, Surabhi
    Jarecha, Rudresh
    Ludajic, Katarina
    Karve, Sayali
    Mikhael, Joseph
    Kheterpal, Arvin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E192 - E193
  • [24] Position statement on the use of bortezomib in multiple myeloma
    Morgan, G. J.
    Davies, F. E.
    Cavenagh, J. D.
    Jackson, G. H.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 (01) : 1 - 10
  • [25] Second primary malignancies in multiple myeloma: an overview and IMWG consensus (vol 28, pg 228, 2017)
    Musto, P.
    Anderson, K. C.
    Attal, M.
    Richardson, P. G.
    Badros, A.
    Hou, J.
    Comenzo, R.
    Du, J.
    Durie, B. G. M.
    Miguel, J. San
    Einsele, H.
    Chen, W. M.
    Garderet, L.
    Pietrantuono, G.
    Hillengass, J.
    Kyle, R. A.
    Moreau, P.
    Lahuerta, J. J.
    Landgren
    Ludwig, H.
    Larocca, A.
    Mahindra, A.
    Cavo, M.
    Mazumder, A.
    McCarthy, P. L.
    Nouel, A.
    Rajkumar, S. V.
    Reiman, A.
    Riva, E.
    Sezer, O.
    Terpos, E.
    Turesson, I.
    Usmani, S.
    Weiss, B. M.
    Palumbo, A.
    ANNALS OF ONCOLOGY, 2018, 29 (04) : 1074 - 1074
  • [26] Bone and Joint Infections in Multiple Myeloma: A Retrospective Review of Patients at Mayo Clinic
    Phuoc, Vania
    Abad, Cybele
    Tande, Aaron
    Tosh, Pritish K.
    Kapoor, Prashant
    Sia, Irene
    Osmon, Douglas
    BLOOD, 2016, 128 (22)
  • [27] The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group consensus statement
    Hussein, M. A.
    Vrionis, F. D.
    Allison, R.
    Berenson, J.
    Berven, S.
    Erdem, E.
    Giralt, S.
    Jagannath, S.
    Kyle, R. A.
    LeGrand, S.
    Pflugmacher, R.
    Raje, N.
    Rajkumar, S. V.
    Randall, R. L.
    Roodman, D.
    Siegel, D.
    Vescio, R.
    Zonder, J.
    Durie, B. G. M.
    LEUKEMIA, 2008, 22 (08) : 1479 - 1484
  • [28] The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement
    M A Hussein
    F D Vrionis
    R Allison
    J Berenson
    S Berven
    E Erdem
    S Giralt
    S Jagannath
    R A Kyle
    S LeGrand
    R Pflugmacher
    N Raje
    S V Rajkumar
    L Randall
    D Roodman
    D Siegel
    R Vescio
    J Zonder
    B G M Durie
    Leukemia, 2008, 22 : 1479 - 1484
  • [29] Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria
    Kentaro Narita
    Daisuke Miura
    Takafumi Tsushima
    Toshiki Terao
    Ayumi Kuzume
    Rikako Tabata
    Masami Takeuchi
    Kosei Matsue
    Scientific Reports, 11
  • [30] International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)
    Giralt, S.
    Stadtmauer, E. A.
    Harousseau, J. L.
    Palumbo, A.
    Bensinger, W.
    Comenzo, R. L.
    Kumar, S.
    Munshi, N. C.
    Dispenzieri, A.
    Kyle, R.
    Merlini, G.
    San Miguel, J.
    Ludwig, H.
    Hajek, R.
    Jagannath, S.
    Blade, J.
    Lonial, S.
    Dimopoulos, M. A.
    Einsele, H.
    Barlogie, B.
    Anderson, K. C.
    Gertz, M.
    Attal, M.
    Tosi, P.
    Sonneveld, P.
    Boccadoro, M.
    Morgan, G.
    Sezer, O.
    Mateos, M. V.
    Cavo, M.
    Joshua, D.
    Turesson, I.
    Chen, W.
    Shimizu, K.
    Powles, R.
    Richardson, P. G.
    Niesvizky, R.
    Rajkumar, S. V.
    Durie, B. G. M.
    LEUKEMIA, 2009, 23 (10) : 1904 - 1912
12345